Michael W. Baughn

Statistics

Publications

Citations

4.5K

H-Index

Active since

2009

Affiliations

University of California San Diego(Current)

Ludwig Cancer Research

Ionis Pharmaceuticals (United States)

Broad Institute

Harvard University

Michael W. Baughn is an author at University of California San Diego specializing in life sciences, neurodegenerative diseases, and neurodegenerative disorders.

ORCID

Publications per year

2009–2025

Publications

Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs

Clotilde Lagier‐Tourenne, Magdalini Polymenidou, Kasey R. Hutt et al. · Nature Neuroscience · 2012 · 750 citations

Life Sciences, Molecular Biology, Neuroscience +10

Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a <i>C9ORF72</i> Repeat Expansion

Dhruv Sareen, Jacqueline G. O’Rourke, Pratap Meera et al. · Science Translational Medicine · 2013 · 691 citations · Full text

Life Sciences, Genetics, Neuroscience +17

Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration

Ze’ev Melamed, Jone López‐Erauskin, Michael W. Baughn et al. · Nature Neuroscience · 2019 · 667 citations

Life Sciences, Genetics, Molecular Biology +13

Targeted degradation of sense and antisense <i>C9orf72</i> RNA foci as therapy for ALS and frontotemporal degeneration

Clotilde Lagier‐Tourenne, Michael W. Baughn, Frank Rigo et al. · Proceedings of the National Academy of Sciences · 2013 · 557 citations · Full text

Life Sciences, Neurobiology, Neurology +14

Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs

Jie Jiang, Qiang Zhu, Tania F. Gendron et al. · Neuron · 2016 · 540 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

1–5 of 17